Coronavirus disease 2019 (COVID-19)

The virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)


  1. RECOVERY Trial Investigators. Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. Press Release June 16th
  2. Li. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19A Randomized Clinical Trial. JAMA 2020;epublished June 3rd
  3. Boulware. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med 2020;epublished June 3rd
  4. Goldman. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med 2020;epublished May 27th
  5. Cao. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial, J Allergy Clin Immunol 2020;epublished May 26th
  6. Beigel. Remdesivir for the Treatment of Covid-19 — Preliminary Report. N Engl J Med 2020;epublished May 22nd
  7. Wang. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020;epublished April 29th
  8. Hung. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 2020;395(10238):1695-1704
  9. Cao. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020;epublished March 18th
  10. Wu. High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial. Br J Anaesth 2020;epublished March 19th
  1. Feng. COVID-19 with Different Severity: A Multi-center Study of Clinical Features. Am J Respir Crit Care Med 2020;epublished April 10th
  2. Klok. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research 2020;epublished April 10th
  3. Shao. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation 2020;epublished April 10th
  4. Grasselli. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;epublished April 6th
  5. Du. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study. Am J Respir Crit Care 2020;epublished April 3rd
  6. Zhou. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-1062
  7. Bhatraju. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med 2020;epublished March 30th
  8. Wang. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Annals of Intensive Care 2020;10:37
  9. Chang. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. Am J Respir Crit Care 2020;epublished March 23rd
  10. Zeng. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA 2020;epublished March 26th
  11. Dong. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. JAMA 2020;epublished March 26th
  12. Arentz. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020;epublished March 19th
  13. Pung. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet 2020;epublished March 16th
  14. Li. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med 2020;382:1199-1207
  15. Cao. Clinical features and short‑term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med 2020;epublished March 2nd
  16. Guan. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;epublished February 28th
  17. Lan. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA 2020;epublished February 27th
  18. Pan. Challenges and countermeasures for organ donation during the SARS-CoV-2 epidemic: the experience of Sichuan Provincial People’s Hospital. Intensive Care Med 2020;epublished February 25th
  19. Wu. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;epublished February 24th
  20. Wei. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA 2020;epublished February 14th
  21. Bai. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020;epublished February 21st
  22. Huang. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506
  23. Chen. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223)P507-513
  24. Chan. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395(10223):514-523
  25. Zhu. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-733



  1. Harapan. Coronavirus disease 2019 (COVID-19): A literature review,Journal of Infection and Public Health 2020;epublished April 8th
  2. Lupia. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. Journal of Global Antimicrobial Resistance 2020;21:22-27
  3. Phua. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet 2020;epublished April 6th
  4. Shah. Guide to Understanding the 2019 Novel Coronavirus. Mayo Clin Proc 2020;95(4):646–652
  5. Sahu. Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV). Ann Transl Med 2020;8(6):393
  6. Wujtewicz. COVID-19 - what should anaethesiologists and intensivists know about it? Anaesthesiol Intensive Ther 2020;epublished March 20th
  7. del Rio. COVID-19—New Insights on a Rapidly Changing Epidemic. JAMA 2020;epublished February 28th
  8. Shanmugaraj. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. Pathogens 2020;9(2):148
  9. Lai. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020;epublished February 17th
  10. Wax. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anesth 2020;epublished February 12th
  11. Peng. Outbreak of a new coronavirus: what anaesthetists should know. Br J Anaesth 2020;epublished February 11th
  12. Arabi. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med 2020;epublished February 10th


  1. Horten. Offline: COVID-19—a reckoning. Lancet 2020;395(10228):935
  2. Horton. Offline: COVID-19 and the NHS—“a national scandal”. Lancet 2020;395(10228):1022
  3. Webster. Canada and COVID-19: learning from SARS. Lancet 2020;395(10228):936-937
  4. Bachireddy. Securing the Safety Net and Protecting Public Health During a Pandemic. Medicaid’s Response to COVID-19. JAMA 2020;epublished March 19th
  5. Parmet. Covid-19 - The Law and Limits of Quarantine. N Engl J Med 2020;epublished March 18th
  6. Rosenbaum. Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line. N Engl J Med 2020;epublished March 18th
  7. Xiao. Taking the right measures to control COVID-19. Lancet Infect Dis 2020;epublished March 5th
  8. Arabi. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med 2020;epublished March 3rd
  9. Zhang. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020;epublished March 3rd
  10. Wang. Response to COVID-19 in Taiwan. Big Data Analytics, New Technology, and Proactive Testing. JAMA 2020;epublished March 3rd
  11. Adalja. Priorities for the US Health Community Responding to COVID-19. JAMA 2020;epublished March 3rd
  12. Lippi. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020;epublished March 3rd
  13. Peckham. COVID-19 and the anti-lessons of history. Lancet 2020;epublished March 2nd
  14. Xie. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020;epublished March 2nd
  15. Olson. Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. JAMA 2020;323(9):885-886
  16. Zhang. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Sci China Life Sci 2020;epublished February 29th
  17. Chen. From SARS-CoV to 2019-nCoV Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends. Chin Med J 2020;epublished February 28th
  18. del Rio. COVID-19—New Insights on a Rapidly Changing Epidemic. JAMA 2020;epublished February 28th
  19. Gates. Responding to Covid-19 — A Once-in-a-Century Pandemic? N Engl J Med 2020;epublished February 28th
  20. Chen. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 2020;epublished February 27th
  21. Nkengasong. Looming threat of COVID-19 infection in Africa: act collectively, and fast. Lancet 2020;epublished February 27th
  22. Stebbing. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020;epublished February 27th
  23. Morens. Escaping Pandora’s Box — Another Novel Coronavirus. N Engl J Med 2020;epublished February 26th
  24. Bouadma. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med 2020;epublished February 26th
  25. Jiang. The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus. Virologica Sinica 2020;epublished February 14th
  26. Guo. Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases. Virologica Sinica 2020;epublished February 11th
  27. Wu. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury. Virologica Sinica 2020;epublished February 7th
  28. Qiao. What are the risks of COVID-19 infection in pregnant women? Lancet 2020;395(10226):760-762
  29. Ghebreyesus. Scientists are sprinting to outpace the novel coronavirus. Lancet 2020;395(10226):762-764
  30. Chen. COVID-19 control in China during mass population movements at New Year. Lancet 2020;395(10226):764-766
  31. Wong. COVID-19 in Singapore—Current Experience. Critical Global Issues That Require Attention and Action. JAMA 2020;epublished February 20th
  32. MacLaren. Preparing for the Most Critically Ill Patients With COVID-19. The Potential Role of Extracorporeal Membrane Oxygenation. JAMA 2020;epublished February 19th
  33. Swerdlow. Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus. Lessons From Previous Epidemics. JAMA 2020;epublished February 11th
  34. del Rio. 2019 Novel Coronavirus—Important Information for Clinicians. JAMA 2020;epublished February 5th
  35. Battegay.  2019-Novel coronavirus (2019-nCoV): estimating the case fatality rate: a word of caution. Swiss Med Wkly 2020;150:w20203
  36. McCloskey. SARS to novel coronavirus: old lessons and new lessons. Epidemiol Infect 2020;148:e22
  37. Russell. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395(10223):473-475
  38. Phelan. The Novel Coronavirus Originating in Wuhan, China. Challenges for Global Health Governance. JAMA 2020;323(8):709-710
  39. Paules. Coronavirus Infections—More Than Just the Common Cold. JAMA 2020;323(8):707-708

Tags: COVID-19, Coronavirus, Pandemic, SARS-CoV-2